161 related articles for article (PubMed ID: 9144127)
1. Intrahepatic cholestasis related to vanishing bile duct syndrome in Hodgkin's disease.
Gottrand F; Cullu F; Mazingue F; Nelken B; Lecomte-Houcke M; Farriaux JP
J Pediatr Gastroenterol Nutr; 1997 Apr; 24(4):430-3. PubMed ID: 9144127
[No Abstract] [Full Text] [Related]
2. Vanishing bile duct syndrome related to DILI and Hodgkin lymphoma overlap: A rare and severe case.
Greca RD; Cunha-Silva M; Costa LBE; Costa JGF; Mazo DFC; Sevá-Pereira T; Nascimento MMC; Pereira IE; Oliveira FC; Faria GAS; Neto FLP; Almeida JRS
Ann Hepatol; 2020; 19(1):107-112. PubMed ID: 31537508
[TBL] [Abstract][Full Text] [Related]
3. Vanishing bile duct syndrome: a possible mechanism for intrahepatic cholestasis in Hodgkin's lymphoma.
Hubscher SG; Lumley MA; Elias E
Hepatology; 1993 Jan; 17(1):70-7. PubMed ID: 7678577
[TBL] [Abstract][Full Text] [Related]
4. Cholestatic liver disease with ductopenia (vanishing bile duct syndrome) in Hodgkin's disease: report of a case.
Guliter S; Erdem O; Isik M; Yamac K; Uluoglu O
Tumori; 2004; 90(5):517-20. PubMed ID: 15656342
[TBL] [Abstract][Full Text] [Related]
5. Resolution of paraneoplastic bile duct paucity following successful treatment of Hodgkin's disease.
Crosbie OM; Crown JP; Nolan NP; Murray R; Hegarty JE
Hepatology; 1997 Jul; 26(1):5-8. PubMed ID: 9214445
[TBL] [Abstract][Full Text] [Related]
6. Severe jaundice, due to vanishing bile duct syndrome, as presenting symptom of Hodgkin's lymphoma, fully reversible after chemotherapy.
Leeuwenburgh I; Lugtenburg EP; van Buuren HR; Zondervan PE; de Man RA
Eur J Gastroenterol Hepatol; 2008 Feb; 20(2):145-7. PubMed ID: 18188038
[TBL] [Abstract][Full Text] [Related]
7. Vanishing bile duct syndrome as a manifestation of Hodgkin's lymphoma: a case report and review of the literature.
Nader K; Mok S; Kalra A; Harb A; Schwarting R; Ferber A
Tumori; 2013; 99(4):e164-8. PubMed ID: 24326854
[TBL] [Abstract][Full Text] [Related]
8. Cholestasis secondary to Hodgkin's disease: report of 2 cases of vanishing bile duct syndrome.
de Medeiros BC; Lacerda MA; Telles JE; da Silva JA; de Medeiros CR
Haematologica; 1998 Nov; 83(11):1038-40. PubMed ID: 9864926
[TBL] [Abstract][Full Text] [Related]
9. Brentuximab vedotin in combination with sequential procarbazine, cyclophosphamide and prednisolone for the management of Hodgkin's lymphoma-associated vanishing bile duct syndrome (VBDS) with severe obstructive liver failure.
Fong M; Boyle S; Gutta N
BMJ Case Rep; 2019 Feb; 12(2):. PubMed ID: 30796069
[TBL] [Abstract][Full Text] [Related]
10. Vanishing bile duct syndrome in Hodgkin's lymphoma: A case report and literature review.
Bakhit M; McCarty TR; Park S; Njei B; Cho M; Karagozian R; Liapakis A
World J Gastroenterol; 2017 Jan; 23(2):366-372. PubMed ID: 28127210
[TBL] [Abstract][Full Text] [Related]
11. Clinical problem-solving. Empirically incorrect.
Schmitt A; Gilden DJ; Saint S; Moseley RH
N Engl J Med; 2006 Feb; 354(5):509-14. PubMed ID: 16452563
[No Abstract] [Full Text] [Related]
12. The vanishing bile duct syndrome in a child with Hodgkin disease.
Ozkan A; Yoruk A; Celkan T; Apak H; Yildiz I; Ozbay G
Med Pediatr Oncol; 2001 Mar; 36(3):398-9. PubMed ID: 11241447
[No Abstract] [Full Text] [Related]
13. Vanishing bile duct syndrome in a Hodgkin's lymphoma patient with fatal outcome despite lymphoma remission.
Aleem A; Al-Katari M; Alsaleh K; AlSwat K; Al-Sheikh A
Saudi J Gastroenterol; 2013; 19(6):286-9. PubMed ID: 24195983
[TBL] [Abstract][Full Text] [Related]
14. Hodgkin's disease associated cholestasis in a man with thymoma.
Opeskin K; Burke M; McCaffrey G; Nandurkar H
Pathology; 2003 Aug; 35(4):349-51. PubMed ID: 12959773
[No Abstract] [Full Text] [Related]
15. Hodgkin lymphoma-related vanishing bile duct syndrome and idiopathic cholestasis: statistical analysis of all published cases and literature review.
Ballonoff A; Kavanagh B; Nash R; Drabkin H; Trotter J; Costa L; Rabinovitch R
Acta Oncol; 2008; 47(5):962-70. PubMed ID: 17906981
[TBL] [Abstract][Full Text] [Related]
16. Complete remission of paraneoplastic vanishing bile duct syndrome after the successful treatment of Hodgkin's lymphoma: a case report and review of the literature.
Rota Scalabrini D; Caravelli D; Carnevale Schianca F; D'Ambrosio L; Tolomeo F; Boccone P; Manca A; De Rosa G; Nuzzo A; Aglietta M; Grignani G
BMC Res Notes; 2014 Aug; 7():529. PubMed ID: 25125318
[TBL] [Abstract][Full Text] [Related]
17. Steatosis and bile duct damage in chronic hepatitis C: distribution and relationships in a group of Northern Italian patients.
Giannini E; Ceppa P; Botta F; Fasoli A; Romagnoli P; Cresta E; Venturino V; Risso D; Celle G; Testa R
Liver; 1999 Oct; 19(5):432-7. PubMed ID: 10533803
[TBL] [Abstract][Full Text] [Related]
18. Cholestasis associated with extrabiliary Hodgkin's disease. Report of three cases and review of four others.
Perera DR; Greene ML; Fenster LF
Gastroenterology; 1974 Oct; 67(4):680-5. PubMed ID: 4412423
[No Abstract] [Full Text] [Related]
19. Hodgkin's lymphoma-related vanishing bile duct syndrome: a case report and literature review.
Wong KM; Chang CS; Wu CC; Yin HL
Kaohsiung J Med Sci; 2013 Nov; 29(11):636-41. PubMed ID: 24183359
[TBL] [Abstract][Full Text] [Related]
20. Liver enzymes and pathology in Hodgkin's disease.
Belliveau RE; Wiernik PH; Abt AB
Cancer; 1974 Aug; 34(2):300-5. PubMed ID: 4152944
[No Abstract] [Full Text] [Related]
[Next] [New Search]
